Mubadala Investment Co PJSC → RECURSION PHARMACEUTICALS, INC. RXRX

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 16/100

Passive Schedule 13G filer baseline
Moderate short days-to-cover (4.4 DTC)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

1 13D/G filings on this issuer

0 other filings besides this one

Filer Track Record

8 filings by this filer

7 other filings in the data moat

Short Interest · settle 2026-10-15

DTC 4.44

161,926,247 shares short · +2.5% vs prior

Other Filings by Mubadala Investment Co PJSC

Filed	Form	Issuer	Stake	Shares
2026-10-14	SCHEDULE 13D/A	Evotec SE	—	0	view →
2024-10-07	SC	Equinox Gold Corp. EQX	—	—	view →
2023-07-13	SC	NextDecade Corp. NEXT	—	—	view →
2023-05-17	SC	Cazoo Group Ltd	—	—	view →
2021-10-19	SC	Virgin Galactic Holdings, Inc SPCE	—	—	view →
2021-01-14	SC	Virgin Galactic Holdings, Inc SPCE	—	—	view →
2019-02-07	SC	ADVANCED MICRO DEVICES INC AMD	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →